A5079380617- Oral health in cancer treatment
- Head and Neck Cancer Studies
- Cancer Diagnosis and Treatment
- Ocular Oncology and Treatments
- Breast Cancer Treatment Studies
- Salivary Gland Disorders and Functions
- Ocular Surface and Contact Lens
- Melanoma and MAPK Pathways
- Cutaneous Melanoma Detection and Management
- Laser Applications in Dentistry and Medicine
- Drug-Induced Ocular Toxicity
- Lung Cancer Diagnosis and Treatment
- Olfactory and Sensory Function Studies
- Nonmelanoma Skin Cancer Studies
- Glaucoma and retinal disorders
- Advanced Radiotherapy Techniques
- Palliative and Oncologic Care
Hospital Haroldo Juaçaba
2011-2024
AC Camargo Hospital
2009-2019
Hospital São Paulo
2009-2012
Hypofractionated radiotherapy (HF) in 15 or 16 daily fractions is well established as an alternative early breast cancer after breast-conserving surgery. Evidences for a whole-breast treatment even shorter, 5-10 fractions, are still scarce. Women 50 years older, with tumor (pT1-2pN0), surgery were eligible to enter this phase II trial and received whole once-weekly hypofractionated (wHF-RT) total dose of 30 Gy, 5 6 Gy. During post-treatment follow-up the toxicity was assessed graduated...
OBJETIVO: Analisar o impacto da terapia nutricional enteral na manutenção do peso corpóreo e necessidade de replanejamento e/ou interrupção radioterapia em pacientes com câncer cabeça pescoço submetidos a intensidade modulada (IMRT). MATERIAIS E MÉTODOS: Foram analisados, retrospectivamente, os IMRT entre janeiro 2005 outubro 2008, inclusão 83 casos. RESULTADOS: A idade mediana foi 58,6 anos. Em apenas cinco (6%) houve tratamento, que variou 4 18 dias, 19 casos (23%) replanejamento....
Hypofractionated radiotherapy in 15 or 16 daily fractions is well established as an alternative early breast cancer after breast-conserving surgery. The evidences for a whole-breast treatment even shorter 5-10 are still scarce. objective of the presenting study to analyse effects adjuvant radiation using once-weekly schedule, 5 fractions. Women 50 years older, with tumor negative lymph nodes (pT1-2N0), surgery margins were eligible enter this phase II trial and received whole...
Abstract Background Trismus is a common adverse effect in patients with head and neck cancer. Patients have limitation of mouth opening (< 35mm), which can compromise maxillomandibular function. The cancer treatment itself lead to its emergence, surgery radiotherapy being the most involved. This study aimed evaluate efficacy PBMT protocol for treating reducing severity trismus undergoing Material Methods Sixteen who had < 35mm were RT included. evaluated daily before after application,...